HERON THERAPEUTICS, INC. /DE/ (HRTX) Net income 2016–2025
HERON THERAPEUTICS, INC. /DE/ (HRTX) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$20.2MFY2025 · since FY2016: -$173.1M → -$20.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$20.2M | -48.7% |
| FY2024 | -$13.6M | +87.7% |
| FY2023 | -$110.6M | +39.3% |
| FY2022 | -$182.0M | +17.5% |
| FY2021 | -$220.7M | +2.9% |
| FY2020 | -$227.3M | -11.0% |
| FY2019 | -$204.7M | -14.5% |
| FY2018 | -$178.8M | +9.4% |
| FY2017 | -$197.5M | -14.1% |
| FY2016 | -$173.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More HRTX financial trends
HRTX RevenueHRTX Net marginHRTX Gross profitHRTX Gross marginHRTX Operating incomeHRTX Operating marginHRTX Operating cash flowHRTX Free cash flowHRTX Capital expendituresHRTX Return on equityHRTX Stock buybacksHRTX Dividends paidHRTX Total assetsHRTX Total liabilitiesHRTX Shareholders’ equityHRTX overview →